XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Registered shares
Additional paid-in capital
Treasury shares
Retained earnings
Accumulated other comprehensive loss
Beginning of the period (in shares) at Mar. 31, 2016   173,106   10,697    
Beginning of the period at Mar. 31, 2016 $ 759,948 $ 30,148 $ 6,616 $ (128,407) $ 963,576 $ (111,985)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 217,155       205,876 11,279
Purchases of registered shares (in shares)       4,027    
Purchases of registered shares (83,786)     $ (83,786)    
Tax effects from share-based awards (1,251)   (1,251)      
Sale of shares upon exercise of stock options and purchase rights 39,574   15,403 $ 24,171    
Sale of shares upon exercise of options and purchase rights (in shares)       (2,513)    
Issuance of shares upon vesting of restricted stock units (18,412)   (30,148) $ 13,985 (2,249)  
Issuance of shares upon vesting of restricted stock units (in shares)       (1,484)    
Share-based compensation 35,976   35,976      
Cash dividends (93,093)       (93,093)  
End of the period (in shares) at Mar. 31, 2017   173,106   10,727    
End of the period balance at Mar. 31, 2017 856,111 $ 30,148 26,596 $ (174,037) 1,074,110 (100,706)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 215,793       208,542 7,251
Purchases of registered shares (in shares)       863    
Purchases of registered shares (30,722)     $ (30,722)    
Sale of shares upon exercise of stock options and purchase rights 41,910   21,315 $ 20,595    
Sale of shares upon exercise of options and purchase rights (in shares)       (1,527)    
Issuance of shares upon vesting of restricted stock units (29,813)   (48,291) $ 18,478    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,536)    
Share-based compensation 44,317   44,317      
Cash dividends (104,248)       (104,248)  
End of the period (in shares) at Mar. 31, 2018   173,106   8,527    
End of the period balance at Mar. 31, 2018 1,050,557 $ 30,148 47,234 $ (165,686) 1,232,316 (93,455)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 245,330       257,573 (12,243)
Purchases of registered shares (in shares)       808    
Purchases of registered shares (32,449)     $ (32,449)    
Sale of shares upon exercise of stock options and purchase rights 18,057   10,526 $ 7,531    
Sale of shares upon exercise of options and purchase rights (in shares)       (575)    
Issuance of shares upon vesting of restricted stock units (30,770)   (51,572) $ 20,802    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,516)    
Share-based compensation 50,467   50,467      
Cash dividends (113,971)       (113,971)  
End of the period (in shares) at Mar. 31, 2019   173,106   7,244    
End of the period balance at Mar. 31, 2019 $ 1,176,339 $ 30,148 $ 56,655 $ (169,802) $ 1,365,036 $ (105,698)